DAVIS JOHN C. JR 4
4 · Magenta Therapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-11+72,500→ 72,500 totalExercise: $10.80Exp: 2031-02-10→ Common Stock (72,500 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2021.